Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

Cancer Gene Therapy

Volumn 6, Issue 5, 1999, Pages 409-422

  Mastrangelo, Michael J ^a   Maguire Jr , Henry C ^a   Eisenlohr, Laurence C ^a   Laughlin, Carol E ^a   Monken, Claude E ^a   McCue, Peter A ^a   Kovatich, Albert J ^a   Lattime, Edmund C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Gene therapy, melanoma; Intratumoral; Recombinant GM CSF; Vaccinia

Indexed keywords

BETA GALACTOSIDASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; FEMALE; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGY; INTRALESIONAL DRUG ADMINISTRATION; MALE; MELANOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; REPORTER GENE; SKIN TUMOR; VACCINIA VIRUS;

ADULT; AGED; ANTIBODIES, VIRAL; BETA-GALACTOSIDASE; FEMALE; GENE THERAPY; GENES, REPORTER; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; VACCINIA VIRUS;

EID: 0033193127     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700066     Document Type: Article

References (30)

1. Prehn RT, Main JM. Immunity to methylcholanthrene induced sarcomas. J Natl Cancer Inst. 1957;18:769-778.
2. Mastrangelo MJ, Sato T, Lattime EC, et al. Cellular vaccine therapies for cancer. In: Foon KA, Muss HB, eds. Biological and Hormonal Therapies of Cancer. Boston: Kluwer Academic Publishers; 1998:35-50.
3. Golumbek PT, Lazenby AJ, Levitsky HI, et al. Treatment of established renal cell cancer by tumor cells engineered to secrete interleukin-4. Science. 1991;254:713-716.
4. Mastrangelo MJ, Maguire HC Jr, Lattime EC. Gene therapy. In: Kurzrock R, Talpaz M, eds. Molecular Biology in Cancer Medicine, 2nd ed. London: Martin Dunitz; 1998: In press.
5. Mackett M, Smith GL, Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol. 1984;49:857-864.
6. Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: co-expression of β-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol. 1985;5:3403-3409.
7. Dookhan D, Kovatich AJ, Miettinen M. Non-enzymatic antigen retrieval in immunohistochemistry comparison between two antigen retrieval solutions and proteolytic digestion. Appl Immunohistochem. 1993;1:149-155.
8. WAFI/CIPI in normal, hyperplastic, and neoplastic uterine tissues. Hum Pathol. 1997;28:60-65.
9. Mastrangelo MJ, Maguire HC Jr, McCue P, et al. A pilot study demonstrating the feasibility of using intratumoral vaccinia injections as vector for gene transfer. Vaccine Res. 1995;4:58-69.
10. Kundig TM, Kalberer CP, Hengartner H, Zinkernagel RM. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. Vaccine. 1993;11:1154-1158.
11. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science. 1987;236:1229-1237.
12. Mehregan DR, Fransway AF, Edmonson JH, Leiferman KM. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. Arch Dennatol. 1992;128:1055-1059.
13. Jones T, Stern A, Lin R. Potential role of granulocytemacrophage colony-stimulating factor as vaccine adjuvant. Eur J Clin Microbiol Infect Dis. 1994;13:S47-S53.
14. Kwak LW, Young HA, Pennington RW, Weeks SD. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colonystimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci USA. 1996;93:10972-10977.
15. Disis ML, Bernhard H, Shiota FM, et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood. 1996; 88:202-210.
16. Harris DT, Matyas G, Mastrangelo MJ, et al. Onco-Vax-P™ vaccine: pilot studies in prostate cancer patients. Proc Am Soc Clin Oncol. 1998;17:428a.
17. Robinson BWS, Mukherjee SA, Davidson A, et al. Cytokine gene therapy or infusion as treatment for solid human cancer. J Immunother. 1998;21:211-217.
18. Mastrangelo MJ, Berd D, Nathan FE, Lattime EC. Gene therapy for human cancer: an essay for clinicians. Semin Oncol. 1996;23:4-21.
19. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA. 1993;90:3539-3543.
20. Moss B. Vaccinia virus: a tool for research and development. Science. 1991;252:1660-1667.
21. Shimizu Y, Hasumi K, Masubuchi K, Okudaira Y. Immunotherapy of tumor-bearing mice utilizing virus help. Cancer Immunol Immunother. 1988;27:223-227.
22. Cooney EL, Collier AC, Greenberg PD, et al. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet. 1991;337:567-572.
23. Cole DJ, Wilson MC, Baron PL, et al. Phase I study of recombinant CEA vaccinia virus vaccine with post-vaccination CEA peptide challenge. Hum Gene Ther. 1996;7: 1381-1394.
24. Fenner F, Henderson DA, Anita I, et al. Smallpox and its Eradication. Geneva, Switzerland: World Health Organization; 1988.
25. Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Committee. MMWR. 1985;34:341-342.
26. Lee SS, Eisenlohr LC, McCue P, et al. In vivo gene therapy of murine tumor using recombinant vaccinia virus encoding GM-CSF. Proc Am Assoc Cancer Res. 1995;36:248.
27. Ju DW, Cao X, Acres B. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits po-tent antitumor response in a murine melanoma model. Cancer Gene Ther. 1997;4:139-144.
28. Vanderplasschen A, Hollinshead M, Smith GL. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but do prevent virus release from infected cells and comet formation. J Gen Virol. 1997;78:2041-2048.
29. Lee SS, Eisenlohr LC, McCue PA, et al. Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors. Cancer Res. 1994;54:3325-3328.
30. Gomella LG, Mastrangelo MJ, Eisenlohr LC, et al. Phase I study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. Proc Am Assoc Cancer Res. 1997;38:9.